-transparent.png){kind=logo}
Two new hypocholesterolemic compounds, ethyl-(+/-)-2-[[alpha-(p-chlorophenyl)-p-tolyl]-oxy]-2-methylbutyrate (Sgd 24 774, beclobrate) and the 3-pyridinylmethyl ester (eniclobrate), have been studied in normocholesterolemic rats. The two compounds are hepatomegalic and they lower serum and liver cholesterol levels but raise liver triglyceride levels. They also reduce the percentage of esterified cholesterol present in the serum. Beclobrate enhances hepatic HMG-CoA reductase activity but does not affect cholesterol-7 alpha hydroxylase. Eniclobrate, on the other hand, increases activity of the hydroxylase but not of HMG-CoA reductase. Neither compound affects cholesterol absorption.
D Kritchevsky, and
S A Tepper, and
M A Mueller, and
D M Klurfeld
October 1967,
Ceskoslovenska gastroenterologie a vyziva,
D Kritchevsky, and
S A Tepper, and
M A Mueller, and
D M Klurfeld
January 1983,
Arzneimittel-Forschung,
D Kritchevsky, and
S A Tepper, and
M A Mueller, and
D M Klurfeld
January 1985,
Arzneimittel-Forschung,
D Kritchevsky, and
S A Tepper, and
M A Mueller, and
D M Klurfeld
November 1968,
Annals of the New York Academy of Sciences,
D Kritchevsky, and
S A Tepper, and
M A Mueller, and
D M Klurfeld
January 1973,
The Journal of nutrition,
D Kritchevsky, and
S A Tepper, and
M A Mueller, and
D M Klurfeld
January 1969,
Acta physiologica Polonica,
D Kritchevsky, and
S A Tepper, and
M A Mueller, and
D M Klurfeld
June 1965,
Endocrinology,
D Kritchevsky, and
S A Tepper, and
M A Mueller, and
D M Klurfeld
August 1996,
The British journal of nutrition,
D Kritchevsky, and
S A Tepper, and
M A Mueller, and
D M Klurfeld
August 1982,
Indian journal of biochemistry & biophysics,
D Kritchevsky, and
S A Tepper, and
M A Mueller, and
D M Klurfeld
June 1996,
Japanese journal of pharmacology,
